Latest Breaking News On - Christina tartaglia - Page 11 : comparemela.com

Disc Medicine to Participate in Upcoming Investor Conferences

Disc Medicine to Participate in Upcoming Investor Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerChristina tartagliaVerge scientific communicationsDisc medicine incUpcoming investorJefferies london healthcare conferenceAnnual healthcare conference

Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates

Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesGayle rossChristina tartagliaJohn quiselWilliam savageAmerican society of hematologyDisc medicine incVerge scientific communicationsKey program updatesDisc medicineAmerican societyAnnual meetingChief executive officerProgram updatesInterim analyses

EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments

– Positive masked safety data update for EYP-1901 in ongoing PAVIA and DAVIO 2 Phase 2 clinical trials as of October 1, 2023 with no drug related .

United statesAmy phillipsJays dukerChristina tartagliaMarcia sellos mouraJay dukerProgram leadership onBetta pharmaceuticalsAmerican academy of ophthalmologyExchange commissionAmerican society of retina specialistsCompany board of directorsEyepoint pharmaceuticals incEyepoint pharmaceuticalsEyepoint pharmaceuticals nasdaqGreen room communications

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023 - EyePoint Pharmaceuticals (NASDAQ:EYPT)

WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal

United statesUniversity of massachusetts medical schoolJays dukerChristina tartagliaAmy phillipsDavidr lallyDavids boyerKeck school of medicineEyepoint pharmaceuticals incGreen room communicationsEquinox sciencesVitreous associates medical groupRetinal surgeon at baystate medical centerEyepoint pharmaceuticalsPoint pharmaceuticalsChief executive officer

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of massachusetts medical schoolDavidr lallyDavids boyerJays dukerChristina tartagliaAmy phillipsEyepoint pharmaceuticals nasdaqKeck school of medicineRetinal surgeon at baystate medical centerEyepoint pharmaceuticalsEquinox sciencesVitreous associates medical groupGreen room communicationsEyepoint pharmaceuticals incPoint pharmaceuticals